Verano Holdings (VRNO) Invested Capital (2021 - 2026)
Verano Holdings (VRNO) posted quarterly Invested Capital of $156000.0 for Q1 2026, down 74.55% year-over-year from $613000.0 in Q1 2025, and down 42.22% quarter-over-quarter from $270000.0 in Q4 2025.
Verano Holdings (VRNO) Invested Capital (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has reported Invested Capital for 6 consecutive years, with $156000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Invested Capital fell 74.55% year-over-year to $156000.0; the TTM figure through Mar 2026 stood at $3.9 million (down 91.49% YoY), while the FY2025 annual figure was $270000.0, down 98.51% from the prior year.
- Invested Capital fell to $156000.0 in Q1 2026 per VRNO's latest filing, from $270000.0 in the prior quarter.
- Across five years, Invested Capital topped out at $258.9 million in Q2 2022 and bottomed at -$4.8 million in Q1 2022.
- Historically, Invested Capital has averaged $28.3 million across 5 years, with a median of $6.7 million in 2023.
- Annual changes were most pronounced in 2023 — Invested Capital surged 410.55% — and 2025, when it plunged 98.85%.
- Verano Holdings' Invested Capital stood at $24.5 million in 2022, then sank by 84.0% to $3.9 million in 2023, then soared by 363.68% to $18.2 million in 2024, then plunged by 98.51% to $270000.0 in 2025, then sank by 42.22% to $156000.0 in 2026.
- Business Quant data shows VRNO's Invested Capital at $156000.0 in Q1 2026, $270000.0 in Q4 2025, and $2.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 9.90 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 4.50 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 3.74 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.74 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 73.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 630.00 Mn |
| 10 | Verano Holdings | 433.71 Mn | 348.51 Mn | 99.70 Mn | 10.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.55 Mn |
| Mar 31, 2026 | 156,000.00 |
| Dec 31, 2025 | 270,000.00 |
| Sep 30, 2025 | 2.94 Mn |
| Jun 30, 2025 | 499,000.00 |
| Mar 31, 2025 | 613,000.00 |
| Dec 31, 2024 | 18.15 Mn |
| Sep 30, 2024 | 22.53 Mn |
| Jun 30, 2024 | 4.06 Mn |
| Mar 31, 2024 | 53.41 Mn |
| Dec 31, 2023 | 3.92 Mn |
| Sep 30, 2023 | 6.70 Mn |
| Jun 30, 2023 | 21.43 Mn |
| Mar 31, 2023 | 14.78 Mn |
| Dec 31, 2022 | 24.46 Mn |
| Sep 30, 2022 | 53.74 Mn |
| Jun 30, 2022 | 258.88 Mn |
| Mar 31, 2022 | -4.76 Mn |
| Dec 31, 2021 | 208.35 Mn |